Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2026-02-20 @ 4:43 PM
Study NCT ID:
NCT01672632
Status:
COMPLETED
Last Update Posted:
2021-05-03
First Post:
2012-08-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fat Cell Size and Overfeeding and Etopic Study
Sponsor:
Pennington Biomedical Research Center
Organization:
Study Overview
Official Title:
Fat Cell Size and Overfeeding and Etopic Study
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EAT
Brief Summary:
It has been shown that large fat cells are associated with more risks for insulin resistance and more cardiovascular risk factors such as high cholesterol or triglycerides.
Detailed Description:
This study will look at fat cell size and how it affects fat deposition, insulin resistance and muscle oxidative capacity. A comparison will be made with the differences between participants with larger versus smaller fat cells in insulin resistance and blood levels of lipids. The study will also determine if characteristics of fat cells and muscle can predict the development of weight gain-induced insulin resistance.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 5R01DK060412 | NIH | None | https://reporter.nih.gov/quic… | View |